An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy
Interventions
DRUG

Biochaperone insulin lispro 0.1 U/kg

Injection of a single dose of BioChaperone insulin lispro at the dose of 0.1 U/kg

DRUG

Biochaperone insulin lispro 0.2 U/kg

Injection of a single dose of BioChaperone insulin lispro at the dose of 0.2 U/kg

DRUG

Biochaperone insulin lispro 0.4 U/kg

Injection of a single dose of BioChaperone insulin lispro at the dose of 0.4 U/kg

DRUG

Humalog®

Injection of a single dose of Humalog® at the dose of 0.2 U/kg

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Adocia

INDUSTRY